Lonza
NEWS
Fridtjof Helemann will leave the company on 31 March 2019, upon reaching retirement age.
Lonza today is publishing unaudited Full-Year 2017 information excluding the Water Care business and taking into consideration additional reporting-related items to enable comparison and inform capital market participants about the upcoming reporting changes prior to our Full-Year 2018 results publication.
New biologics facility, scheduled to be operational in 2020, will provide development and manufacturing facilities from early- to late-clinical and early-commercial stages
Lonza and Platinum Equity jointly announced today that Platinum Equity has entered into a definitive agreement with Lonza to acquire Lonza’s Water Care business and operations for USD 630 million.
Acquisition further strengthens Lonza’s commitment to drive the next generation of manufacturing patient-specific and personalized therapies
Businesses in Pharma & Biotech and in Consumer Health – including capsule and combined ingredient and dosage form offerings – continued to drive growth
Lonza is holding a series of events as part of this year’s Capital Markets Day from 24-26 September in Zurich and Visp (CH).
CHF 400 million investment in Lonza’s biopark in Visp (CH) to expand IbexTM Solutions with two innovative offerings
Akouos, based in Boston, announced a Series A financing worth $50 million. The round was led by seed investors 5AM Ventures and New Enterprise Associates (NEA).
JOBS
IN THE PRESS